Conversely, signaling of IL-12 and especially IL-23, which is pathogenetically related to psoriasis, is mediated by Tyk2/Jak2; selective inhibition of Tyk2 avoids interference with multiple Jak2 mediated pathways and potential hematopoietic or thromboembolic adverse events [14,15]. This evidence concerns the gene JAK2 and psoriasis.